Back to Dimensional Fund Advisors LP Dimensional Fund Advisors LP

ACRSACRS

Showing 9 of 27 quarters

Position history for Dimensional Fund Advisors LPDimensional Fund Advisors LP's holdings in Aclaris Therapeutics, Inc.

Yes. Dimensional Fund Advisors holds 513,840 shares of ACRS (Aclaris Therapeutics), worth $2.7M, as of its Q3 2026 13F filing. The share count is unchanged from Q2 2026. Dimensional Fund Advisors has held ACRS since Q3 2022, across 17 quarterly 13F filings.

Current Value

$2.7M

Current Shares

513,840

Total Value Change

+$2.6M

Total Shares Change

+437,030

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Unchanged
513,840
0.0%
$2.7M0.0%$5.26
0
2026-Q2
Increased
513,840
+0.5%
$2.7M0.0%$5.29
26
2026-Q1
Increased
511,461
+88.8%
$1.9M0.0%$3.75
41
2025-Q4
Increased
270,850
+64.9%
$814,6440.0%$3.01
36
2025-Q3
Decreased
164,244
-20.8%
$312,1750.0%$1.90
0
2025-Q2
Decreased
207,273
-41.6%
$294,6070.0%$1.42
0
2025-Q1
Increased
354,849
+48.1%
$543,2550.0%$1.53
33
2024-Q4
Increased
239,595
+211.9%
$594,1950.0%$2.48
39
2024-Q3
Increased
76,810
+0.1%
$88,3320.0%$1.15
15

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used